| abstract |
The invention relates to the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for the prophylaxis and / or the control of inflammation processes which are caused by increased leukotriene formation in human or veterinary medicine and the use of pure boswellic acid or a physiologically acceptable salt, a derivative, a salt of the derivative or a herbal preparation containing boswellic acid for the manufacture of a medicament for the treatment of inflammation processes which are caused by increased leukotriene formation, in human or veterinary medicine. |